Precision Biosciences (DTIL) Liabilities from Discontinued Operations (2022 - 2025)
Precision Biosciences (DTIL) has disclosed Liabilities from Discontinued Operations for 4 consecutive years, with 885000.0 as the latest value for Q3 2025.
- Quarterly Liabilities from Discontinued Operations fell 32.13% to 885000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 885000.0 through Sep 2025, down 32.13% year-over-year, with the annual reading at 1204000.0 for FY2024, 52.09% down from the prior year.
- Liabilities from Discontinued Operations for Q3 2025 was 885000.0 at Precision Biosciences, roughly flat from 885000.0 in the prior quarter.
- The five-year high for Liabilities from Discontinued Operations was 3465000.0 in Q4 2022, with the low at 885000.0 in Q1 2025.
- Average Liabilities from Discontinued Operations over 4 years is 1559200.0, with a median of 1304000.0 recorded in 2024.
- Peak annual rise in Liabilities from Discontinued Operations hit 20.54% in 2024, while the deepest fall reached 52.09% in 2024.
- Over 4 years, Liabilities from Discontinued Operations stood at 3465000.0 in 2022, then dropped by 27.47% to 2513000.0 in 2023, then crashed by 52.09% to 1204000.0 in 2024, then decreased by 26.5% to 885000.0 in 2025.
- According to Business Quant data, Liabilities from Discontinued Operations over the past three periods came in at 885000.0, 885000.0, and 885000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.